跳至主要内容
临床试验/PACTR201901535105039
PACTR201901535105039已完成未知

Prospective study comparing between the effects of fibrinogen concentrate, and recombinant activated factor VII on reduction of blood products transfusion requirements in elective coronary artery bypass surgery

Ain Shams University Hospitals0 个研究点目标入组 80 人开始时间: 2018年12月20日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
All

入选标准

  • Patients scheduled coronary artery bypass grafting (CABG)
  • persistent clinical evidence of bleeding, after heparin reversal, requiring hemostatic therapy, as assessed by anesthetist.

排除标准

  • Patients with previous cardiac surgery,
  • patients with previous history of coagulopathy or thromboembolic manifestations.
  • Patients with history of stroke.

研究者

相似试验

Prospective study comparing between the effects of... | 临床试验